Get started

Break

EUR/NZD Fibonacci Span long termIn my opinion we are still in an uptrend in the market, the last span placement has a clear high low. It is trending bearish on lower time frame. You can clearly see how the market reacts to previous fib span lines. Simply go to the smaller time frames to check for break of resistance & retests to find which line has more bearing. Then, you can return to the weekly & come up with your own projections. I save the charts in this format, then make copies when I go the lower time frames for mark ups & the typical 5 - 15 minute trades I usually make.
by Matt_Reily
$CASI KST Buy Signal CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical products and various therapeutics in China, the United States, and internationally. The company's product pipeline includes EVOMELA, a melphalan hydrochloride for injection primarily for use as a high-dose conditioning treatment prior to hematopoietic progenitor cell transplantation in patients with multiple myeloma. Its product pipeline also comprise CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma; CID-103, an anti-CD38 monoclonal antibody being for the treatment of patients with multiple myeloma; ZEVALIN, a CD20-directed radiotherapeutic antibody, to treat patients with NHL; and Thiotepa, a chemotherapeutic agent, which has multiple indications including use as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In addition, the company offers MARQIBO, a microtubule inhibitor, approved by the FDA for the treatment of adult patients with Philadelphia chromosome-negative ALL; and Octreotide LAI formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumours, as well as developing a portfolio of 25 FDA-approved abbreviated new drug applications. It has licensing agreements with Black Belt Therapeutics Limited; Juventas Cell Therapy Ltd.; Pharmathen Global BV; and Cleave Therapeutics, Inc. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is based in Rockville, Maryland.
NASDAQ:CASILong
by UnknownUnicorn19246015
Don't miss this amazing EURGBP break!Hey there, EURGBP is going to break the downtrend from upper line, it is following an small uptrend even in price and rsi and I'm expecting a 0.70% (60 pips) rise on break as first movement. After that, the price will keep going up and up, we can't know how much it can go but you can use my safe pivots trading. SL == break below 0.85847 TP1 == 0.86691 TP2 == 0.87223 TP3 == 0.87930 This is not an investing advice, please calculate your risk and margin trading.
Long
by egecvn